Skip to main content

Upadacitinib is a Double Edged Vascular Sword in GCA

Dr. David Liew discusses abstracts O751, O738, and O734 presented at the 2025 ACR Convergence meeting in Chicago.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×